Addressing Low-Value Care and a Better Benefit Design at the V-BID Summit

March 29, 2018

As the country searches a new way to address cost of care, value-based insurance design (VBID), is gaining traction as one way of encouraging the use of high-value services and discouraging the use of low-value services.

As the country searches a new way to address cost of care, value-based insurance design (VBID), is gaining traction as one way of encouraging the use of high-value services and discouraging the use of low-value services. VBID would give patients access to treatments and services with high clinical value at reduced or no cost sharing. Currently, health plans tend to value all treatments and services as equal in clinical value to all patients, even though this is not the reality.

On March 14, the University of Michigan’s V-BID Center hosted its annual VBID Summit with discussions on aligning around value, how public payers are adopting VBID principles, addressing the use of low-value care services, and creating a smarter high-deductible health plan.

In this podcast, we speak with 3 speakers from the Summit. First up is Michelle Drozd of the Pharmaceutical Research and Manufacturers of America, known as PhRMA, sat on a panel discussing smarter high-deductible health plans.

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Listen above or through one of these podcast services:

The Challenge of Addressing Low-Value Care Once It's Identified

How Public Payers Are Adopting VBID Principles Despite Constraints

Aligning Around Value: Challenges With Quality Measures and Implementing Clinical Nuance

Path to a Smarter High-Deductible Plan Includes Flexibility, Disruptive Innovation

Read coverage of the panels from the V-BID Summit: